Home / Health / England Trialing Multi-Cancer Blood Tests in GPs
England Trialing Multi-Cancer Blood Tests in GPs
5 Nov
Summary
- Trial assesses if blood tests aid earlier cancer diagnosis and survival.
- Tests detect multiple cancers and their origin in the body.
- Over 200 GP practices in England will join the trial.
A significant clinical trial is underway across England to determine if routine use of simple blood tests can lead to earlier cancer diagnosis and better survival outcomes. These innovative tests, developed by the University of Birmingham in collaboration with partners, aim to identify signs of 14 different cancers from a single blood sample and pinpoint their location within the body.
The trial will involve at least 200 general practitioner (GP) practices within the National Health Service, encompassing over 20,000 patients. Participation is open to individuals aged 45 and above who present with persistent abdominal symptoms such as bloating or discomfort. Technologies including artificial intelligence and protein measurement are being utilized to enhance the tests' accuracy.
This initiative seeks to assess how effectively these blood tests can support GPs in identifying patients requiring urgent treatment. The findings will be crucial in deciding whether to implement these diagnostic tools on a national scale, potentially addressing the high cancer mortality rates observed in Britain.
